Collegium Pharmaceutical Inc
NASDAQ:COLL

Watchlist Manager
Collegium Pharmaceutical Inc Logo
Collegium Pharmaceutical Inc
NASDAQ:COLL
Watchlist
Price: 45.02 USD -0.66%
Market Cap: $1.4B

Profitability Summary

Collegium Pharmaceutical Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Collegium Pharmaceutical Inc

Margins Comparison
Collegium Pharmaceutical Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Collegium Pharmaceutical Inc
NASDAQ:COLL
1.4B USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.4B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
547B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
265.9B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
147.8B USD
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Collegium Pharmaceutical Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Collegium Pharmaceutical Inc
NASDAQ:COLL
1.4B USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.4B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
547B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
265.9B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
147.8B USD
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Collegium Pharmaceutical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate